Shares of Novartis were climbing higher on Friday after the Food and Drug Administration (FDA) approved Novartis’ $2.1 million gene therapy Zolgensma. Zolgensma is a one-time treatment for spinal muscular atrophy and is the world’s most expensive drug now. Previously Novartis had said that the treatment could cost anywhere from $1.5 to $5 million but … Continue reading “Novartis’ Gene Therapy Gets Nod from FDA”
Biotech & Pharma
Biotech & Pharma
Merck & Co Inc. Agrees to Buy Peloton Therapeutics
In a $1.05 billion transaction, Merck & Co Inc. has announced this week that it…
May 22, 2019
Biotech & Pharma
Genetic Technologies Limited Announces Completion of Two Genetic Risk Tests for Colorectal Cancer and Breast Cancer
Genetic Technologies Limited announced this week the successful completion of two ground-breaking tests branded GeneType…
May 14, 2019
Biotech & Pharma
AstraZeneca and Merck’s Breast Cancer Drug Lynparza Gets EU Approval
AstraZeneca plc AZN and partner Merck announced this week that the European Commission has approved…
April 11, 2019
Biotech & Pharma
AstraZeneca Acquires Joint Development and Commercialization Rights to a Very Exciting Cancer Candidate
AstraZeneca (AZN) announced this week that it has acquired joint development and commercialization rights to…
March 30, 2019
Biotech & Pharma
Pfizer Is Buying a Big Stake in This Company
Pharmaceutical giant Pfizer Inc. announced that it is buying a stake in French gene company…
March 22, 2019
Biotech & Pharma
FDA Grants Accelerated Approval for Roche Holdings Tecentriq Drug for Breast Cancer
It was this week that Roche Holdings AG RHHBY announced that the Food and Drug…
March 14, 2019
Biotech & Pharma
Johnson & Johnson Gets Approval from FDA for Nasal Spray Antidepressant
It was a day of celebration for Johnson & Johnson on Tuesday after the pharmaceutical…
March 6, 2019
Biotech & Pharma
The Maker of OxyContin Explores Filing For Bankruptcy
Purdue Pharma LP, the company that makes OxyContin, is exploring bankruptcy according to sources familiar…
March 5, 2019
Biotech & Pharma
Johnson & Johnson May Soon Gain FDA Approval for Blockbuster Depression Drug
Pharmaceutical giant Johnson & Johnson could be on the cusp of gaining approval from the…
February 13, 2019
Biotech & Pharma
Bristol-Myers Has Withdrew its Application for Combination Lung Cancer Treatment
Bristol-Myers Squibb Co had a surprising announcement on Thursday as it reported financial results. The…
January 24, 2019
Biotech & Pharma
Johnson & Johnson Beats in Fourth Quarter
Johnson & Johnson reported its fourth quarter financial report ahead of the bell on Tuesday.…
January 22, 2019
Biotech & Pharma
Eli Lilly to Acquire Loxo Oncology for $8 Billion
Eli Lilly has announced that it will be acquiring Loxo Oncology for around $8 billion…
January 7, 2019
Biotech & Pharma
Pfizer to Raise the Prices of 41 Prescription Drugs in January
Despite criticism from President Trump about increasing drug prices, Pfizer will be raising its prices…
November 17, 2018